Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Visualized Experiments

• Publication date

  2015-11-08

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3791/52424PMID 26575262PMCID PMC4692696
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutic drug monitoring of ciclosporin A and tacrolimus in heart lung transplant patients using dried blood spots

  2014cited by this paper
• Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

  2014cited by this paper
• Determining the effect of immunosuppressant adherence on graft failure risk among renal transplant recipients

  2014cited by this paper
• Clinical validation and implementation of a multiplexed immunosuppressant assay in dried blood spots by LC-MS/MS.

  2013cited by this paper
• PharmGKB summary: cyclosporine and tacrolimus pathways

  2013cited by this paper
• Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery.

  2013cited by this paper
• Analysis of tacrolimus and creatinine from a single dried blood spot using liquid chromatography tandem mass spectrometry.

  2013cited by this paper
• State-of-the-art dried blood spot analysis: an overview of recent advances and future trends.

  2013cited by this paper
• Development and validation of a sensitive LC-MS/MS method for determination of tacrolimus on dried blood spots.

  2012cited by this paper
• Simultaneous measurement of cyclosporin A and tacrolimus from dried blood spots by ultra high performance liquid chromatography tandem mass spectrometry.

  2012cited by this paper
• Dried blood spots, pharmacokinetic studies and better medicines for children.

  2011cited by this paper
• The current role of liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressant and antiretroviral drugs.

  2011cited by this paper
• A survey of apparent blood volumes and sample geometries among filter paper bloodspot samples submitted for lead screening.

  2009cited by this paper
• Development and validation of a semi-automated assay for the highly sensitive quantification of Biolimus A9 in human whole blood using high-performance liquid chromatography-tandem mass spectrometry.

  2009cited by this paper
• Liquid chromatography-mass spectrometry measurement of tacrolimus in finger-prick samples compared with venous whole blood samples

  2009cited by this paper
• Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography-mass spectrometry.

  2009cited by this paper
• Analysis of cyclosporin A in dried blood spots using liquid chromatography tandem mass spectrometry.

  2009cited by this paper
• Dried Blood Spot Methods in Therapeutic Drug Monitoring: Methods, Assays, and Pitfalls

  2009cited by this paper
• Dried blood spot measurement of tacrolimus is promising for patient monitoring.

  2007cited by this paper
• Therapeutic drug monitoring of tacrolimus with the dried blood spot method.

  2007cited by this paper
• Dried blood spot measurement: application in tacrolimus monitoring using limited sampling strategy and abbreviated AUC estimation

  2007cited by this paper
• Current issues in pediatric transplantation

  2006cited by this paper
• Monitoring of cyclosporine levels in transplant recipients using self‐administered fingerprick sampling

  2006cited by this paper
• Is The Time For The Change Of Digoxin Therapeutic Range In The Treatment Of Chronic Heart Failure?: 38

  2005cited by this paper
• Fingerprick blood samples can be used to accurately measure tacrolimus levels by tandem mass spectrometry

  2005cited by this paper
• Simultaneous and Rapid Analysis of Cyclosporin A and Creatinine in Finger Prick Blood Samples Using Liquid Chromatography Tandem Mass Spectrometry and Its Application in C2 Monitoring

  2002cited by this paper
• Ion suppression effects in liquid chromatography-electrospray-ionisation transport-region collision induced dissociation mass spectrometry with different serum extraction methods for systematic toxicological analysis with mass spectra libraries.

  2002cited by this paper
• Mechanisms of Clinically Relevant Drug Interactions Associated with Tacrolimus

  2002cited by this paper
• International Federation of Clinical Chemistry/International Association of Therapeutic Drug Monitoring and Clinical Toxicology Working Group on Immunosuppressive Drug Monitoring

  2002cited by this paper
• Use of filter paper for the collection and analysis of human whole blood specimens.

  2001cited by this paper
• Therapeutic drug monitoring for immunosuppressants.

  2001cited by this paper
• Low intraindividual variability of cyclosporin A exposure reduces chronic rejection incidence and health care costs.

  2000cited by this paper
• Automated, fast and sensitive quantification of drugs in blood by liquid chromatography-mass spectrometry with on-line extraction: immunosuppressants.

  2000cited by this paper
• THERAPEUTIC DRUG MONITORING OF CYCLOSPORINE AND TACROLIMUS

  1998cited by this paper
• Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus.

  1998cited by this paper
• Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection - A report of the European Tacrolimus Multicenter Renal Study Group

  1997cited by this paper
• A Comparison Of Tacrolimus (fk506) And Cyclosporine For Immunosuppression After Cadaveric Renal Transplantation1

  1997cited by this paper
• Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation.

  1997cited by this paper
• Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group.

  1997cited by this paper
• A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.

  1997cited by this paper
• Quality assessment issues of new immunosuppressive drugs and experimental experience.

  1996cited by this paper
• Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection.

  1996cited by this paper
• Consensus Document: Therapeutic Monitoring of Tacrolimus (FK‐506)

  1995cited by this paper
• Consensus document: therapeutic monitoring of tacrolimus (FK-506).

  1995cited by this paper
• A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation.

  1994cited by this paper
• Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group.

  1994cited by this paper
• Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation

  1992cited by this paper
• FK 506 for liver, kidney, and pancreas transplantation.

  1989cited by this paper
• FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.

  1987cited by this paper
• Discovery of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis.

  1987cited by this paper
• Physicochemical properties of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis.

  1987cited by this paper

• Microsampling techniques and patient-centric therapeutic drug monitoring of immunosuppressants.

  2025cites this paper
• Stimuli-Responsive Polymeric Conjugates of Tacrolimus: A pH/Redox-Triggered Approach toward Precision Drug Delivery.

  2025cites this paper
• Biological Fluid Microsampling for Therapeutic Drug Monitoring: A Narrative Review

  2023cites this paper
• Potential profound fluctuation in tacrolimus concentration on consumption of pomegranate rind extract: A Pharmacokinetic Experiment

  2023cites this paper
• Volumetric Absorptive Microsampling to Enhance the Therapeutic Drug Monitoring of Tacrolimus and Mycophenolic Acid: A Systematic Review and Critical Assessment

  2023cites this paper
• Redox-Responsive Hyaluronic Acid-Tacrolimus Conjugate: Synthesis, Characterization, and In Vitro Immunosuppressive Activity.

  2023cites this paper
• Automation of tacrolimus measurement on volumetric absorptive microsampling devices by tandem mass spectrometry.

  2023cites this paper
• Long-term normalization of calcineurin activity in model mice rescues Pin1 and attenuates Alzheimer’s phenotypes without blocking peripheral T cell IL-2 response

  2023cites this paper
• ADAPTATION OF “DRIED BLOOD DROP” METHOD FOR THERAPEUTIC DRUG MONITORING

  2022cites this paper
• Dried blood microsampling-assisted therapeutic drug monitoring of immunosuppressants: An overview.

  2022cites this paper
• A Volumetric Absorptive Microsampling UPLC-MS/MS Method for Simultaneous Quantification of Tacrolimus, Mycophenolic Acid and Creatinine in Whole Blood of Renal Transplant Recipients

  2022cites this paper
• Application of a new volumetric microsampling device for quantitative bioanalysis of immunosuppression.

  2022cites this paper
• Quantitation of Tacrolimus in Human Whole Blood Samples Using the MITRA Microsampling Device

  2020cites this paper
• Volumetric Microsampling of Capillary Blood Spot vs Whole Blood Sampling for Therapeutic Drug Monitoring of Tacrolimus and Cyclosporin A: Accuracy and Patient Satisfaction.

  2020cites this paper
• Validation of a Capillary Dry Blood Sample MITRA-Based Assay for the Quantitative Determination of Systemic Tacrolimus Concentrations in Transplant Recipients

  2020cites this paper
• A review of recent advances in microsampling techniques of biological fluids for therapeutic drug monitoring.

  2020cites this paper
• A Nucleic Acid Nanostructure Built through On-electrode Ligation for Electrochemical Detection of a Broad Range of Analytes.

  2019cites this paper
• Application of dried blood spot for analysis of low molecular weight fraction (metabolome) of blood

  2018cites this paper
• A simple and highly sensitive on-line column extraction liquid chromatography-tandem mass spectrometry method for the determination of protein-unbound tacrolimus in human plasma samples.

  2018cites this paper
• Preanalytical considerations in therapeutic drug monitoring of immunosuppressants with dried blood spots

  2018cites this paper
• Assessment of tacrolimus intrapatient variability in stable adherent transplant recipients: Establishing baseline values

  2018cites this paper
• Label-Free Quantification of Anticancer Drug Imatinib in Human Plasma with Surface Enhanced Raman Spectroscopy.

  2018cites this paper
• A next-generation newborn screening pilot study: NGS on dried blood spots detects causal mutations in patients with inherited metabolic diseases

  2017cites this paper
• Advances in Clinical Mass Spectrometry.

  2017cites this paper
• Dried Blood Spot Sampling for Tacrolimus and Mycophenolic Acid in Children: Analytical and Clinical Validation

  2017cites this paper
• Experiences from using LC-MS/MS for analysis of immunosuppressive drugs in a TDM service.

  2016cites this paper
• Advantages and Challenges of Dried Blood Spot Analysis by Mass Spectrometry Across the Total Testing Process

  2016cites this paper
• A Steady‐State Head‐to‐Head Pharmacokinetic Comparison of All FK‐506 (Tacrolimus) Formulations (ASTCOFF): An Open‐Label, Prospective, Randomized, Two‐Arm, Three‐Period Crossover Study

  2016cites this paper
• LC-MS/MS as a tool for TDM services: Where are we?

  2016cites this paper